In one paragraphReview in The journals of gerontology. Series A, Biological sciences and medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Chixiang ChenDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-5474-2833 Terrence E MurphyDepartment of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Jaime Lynn SpeiserDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.ORCID 0000-0003-0679-8730 Karen Bandeen-RocheDepartments of Biostatistics, Medicine and Nursing, Johns Hopkins University, Baltimore, Maryland, USA.
Heather AlloreDepartment of Internal Medicine, Yale School of Medicine and Department of Biostatistics Yale School of Public Health, New Haven, Connecticut, USA.ORCID 0000-0001-7685-8175 Thomas G TravisonMarcus Institute for Aging Research, Hebrew Senior Life, Boston, Massachusetts, USA.ORCID 0000-0002-1030-7175 Michael GriswoldDepartments of Medicine and Data Science, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Michelle ShardellDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-5283-2082 Funding
Training Core (I)U54AG063546 · NIA · BROWN UNIVERSITY · PI JOSEPH E. GAUGLER · 2019 to 2026
$125.9MYale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Lauren Ferrante · 2002 to 2026
$37.9MPenn State Clinical and Translational Science InstituteUL1TR002014 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KRASCHNEWSKI, JENNIFER L. · 2016 to 2025
$33.7MTechnological Assessment and Solutions Core - RC4P30AG021334 · NIA · JOHNS HOPKINS UNIVERSITY · PI Jeremy D Walston · 2003 to 2026
$33.2MYale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2020 to 2026
$30.2MResearch Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI Corinne Pettigrew · 2020 to 2026
$29.3MUniversity of Maryland Claude D. Pepper Older Americans Independence Center (UM-OAIC)P30AG028747 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI ALICE S. RYAN · 2006 to 2026
$28.9MEPIDEMIOLOGY AND BIOSTATISTICS OF AGINGT32AG000247 · NIA · JOHNS HOPKINS UNIVERSITY · PI Karen J. Bandeen-Roche · 1996 to 2026
$13.2MStatistical methods for vitamin D targets for functional outcomes in older adultsR01AG048069 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI SHARDELL, MICHELLE DENISE · 2015 to 2025
$4.3MMethods to Test the Role of Age-related Lifestyle and Vaginal Microenvironment Changes and the Prevention, Treatment, and Progression of Genitourinary Syndrome of MenopauseR01AG069915 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI REBECCA M. BROTMAN, Michelle Denise Shardell · 2021 to 2026
$3.1MMethods to Test Biomarkers of Aging as Shared Determinants of Alzheimers Disease and Related Dementias and Physical DisabilityR01AG079854 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI SHARDELL, MICHELLE DENISE · 2023 to 2025
$2.3MStatistical Models and Mechanisms Linking Biomarkers of Aging to Cognitive-Physical Decline and DementiaRF1NS128360 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI SHARDELL, MICHELLE DENISE · 2022 to 2022
$2.2MNCATS NIH HHS UL1 TR002014NIA NIH HHS K25 AG068253NIA NIH HHS P30 AG021334NIA NIH HHS P30 AG021342NIA NIH HHS P30 AG028747NIA NIH HHS P30 AG066507NIA NIH HHS P30 AG066508NIA NIH HHS R01 AG048069NIA NIH HHS R01 AG069915NIA NIH HHS R01 AG079854NIA NIH HHS R01 AG089377NIA NIH HHS R03 AG070178NIA NIH HHS T32 AG000247NIA NIH HHS U54 AG063546NIH HHS R01 AG048069NINDS NIH HHS RF1 NS128360
6 · The paper itselfAbstract
Introduced in 2010, the subdiscipline of gerontologic biostatistics was conceptualized to address the specific challenges of analyzing data from clinical research studies involving older adults. Since then, the evolving technological landscape has led to a proliferation of advancements in biostatistics and other data sciences that have significantly influenced the practice of gerontologic research, including studies beyond the clinic. Data science is the field at the intersection of statistics and computer science, and although the term "data science" was not widely used in 2010, the field has quickly made palpable effects on gerontologic research. In this Review in Depth, we describe multiple advancements of biostatistics and data science that have been particularly impactful. Moreover, we propose the subdiscipline of "gerontologic biostatistics and data science," which subsumes gerontologic biostatistics into a more encompassing practice. Prominent gerontologic biostatistics and data science advancements that we discuss herein include cutting-edge methods in experimental design and causal inference, adaptations of machine learning, the rigorous quantification of deep phenotypic measurement, and analysis of high-dimensional -omics data. We additionally describe the need for integration of information from multiple studies and propose strategies to foster reproducibility, replicability, and open science. Lastly, we provide information on software resources for gerontologic biostatistics and data science practitioners to apply these approaches to their own work and propose areas where further advancement is needed. The methodological topics reviewed here aim to enhance data-rich research on aging and foster the next generation of gerontologic researchers.
Indexed as
AgingBig DataBiostatisticsData ScienceGeriatricsAgedBiomedical ResearchHumansResearch DesignEpidemiologyMachine learningMeasurement-Omics
Identifiers
PMID39500720
PMCPMC11683485
What OpenQuestion holds
Textmetadata
Read underepoch 390